Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions.
Sunovion’s vision is to lead the way to a healthier world. Our spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives.
Sunovion, an indirect, wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is headquartered in Marlborough, Mass. More information about Sunovion Pharmaceuticals Inc. is available at www.sunovion.com.